Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Pain 1

Interventions

Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Nivolumab 3 ulixertinib 2 binimetinib 2 Ipilimumab 2 Immunoglobulin G 2 Disulfides 2 Cetuximab 2 CTLA-4 Antigen 2 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 trametinib 1 tipifarnib 1 temsirolimus 1 selpercatinib 1 sapanisertib 1 repotrectinib 1 relatlimab 1 pertuzumab 1 palbociclib 1 osimertinib 1 omipalisib 1 larotrectinib 1 ipatasertib 1 erdafitinib 1 defactinib 1 dabrafenib 1 copanlisib 1 capivasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Range of Motion, Articular × 30 days × Clear all

NCT07623005 2026-06-03

PMRT-ThyCa

University of Faisalabad

Phase NA Completed

Pain, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡